/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

First Bight Ventures
HoustonSeed–Series A$1M – $2M
22 people
Pebblebed
San FranciscoPre-Seed–Series A$2M – $6M
10 people
Eckuity
CypressGrowth
24 people
Breakout Ventures
San FranciscoSeed–Series A$500K – $6M
14 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Phoenix Venture Partners
San MateoSeed–Series A$100K – $3M
10 people
R7 Partners
ChicagoSeed–Series A$100K – $5M
10 people
Monograph Capital Partners
Fort WorthSeed–Growth
21 people
Aditum Bio
OaklandSeries A–Series B
25 people
Epidarex Capital
BethesdaSeed–Series A$2.5M – $6.3M
13 people
Questa Capital
San FranciscoGrowth$15M – $40M
16 people
Sanderling Ventures
San MateoSeed$50K – $1M
7 people
Bridge Bank
San JoseSeed–Late Stage
20 people
Cure Ventures
BostonPre-Seed–Series A
20 people
Lifeforce Capital
Chevy ChaseSeed–Series C$500K – $5M
4 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
Elm Street Ventures
New HavenSeed–Series A$250K – $1M
15 people
SpringTide Ventures
BostonPre-Seed–Series A$500K – $5M
15 people
Adverb Ventures
San FranciscoPre-Seed–Series A$500K – $5M
8 people
DSW Ventures
ManchesterPre-Seed–Series A$100K – $1M
17 people
HealthQuest Capital
Redwood CityGrowth–Late Stage
14 people
Colorado BioScience Association
Denver
2 people
Suncoast Ventures
San FranciscoPre-Seed–Series A$50K
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.